N-[2-(2,5-二甲氧基苯基)乙基]邻苯二甲酰亚胺 | 64584-26-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异吲哚及其衍生物
• 中文名称: N-[2-(2,5-二甲氧基苯基)乙基]邻苯二甲酰亚胺
• 英文名称: N-(2-(2,5-dimethoxyphenyl)ethyl)phthalimide
• 英文别名: N-[2-(2,5-Dimethoxyphenyl)ethyl]phthalimide；2-[2-(2,5-dimethoxyphenyl)ethyl]isoindole-1,3-dione
• CAS: 64584-26-5
• 化学式: C₁₈H₁₇NO₄
• 分子量: 311.337
• InChiKey: UBRSAHBMQOQDSR-UHFFFAOYSA-N

物化性质

• 溶解度：
  可溶于氯仿（少许）、DMSO（少许）、甲醇（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  23
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  55.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  N-[2-(2,5-二甲氧基苯基)乙基]邻苯二甲酰亚胺 在 三氟甲磺酸 作用下， 以 二氯甲烷 为溶剂， 反应 12.0h， 以87%的产率得到12b-hydroxy-1,4-dimethoxy-5,12b-dihydro-6H-isoindolo[1,2-a]isoquinolin-8-one
  参考文献：
  名称：

  Brønsted acid assisted activation of imide carbonyl group: regioselective synthesis of isoindoloisoquinolinone alkaloid (±)-nuevamine

  摘要：

  用三氟甲磺酸活化酰亚胺羰基有助于苯乙基邻苯二甲酰亚胺的分子内环化，从而得到融合的异吲哚异喹啉酮骨架。利用这种方法，首次成功地进行了异吲哚异喹啉酮生物碱 (±)-nuevamine 的一锅区域选择性合成。

  DOI：

  10.1039/c1ob06349a
• 作为产物：
  描述：

  苯酐 、 2,5-二甲氧基苯乙胺 生成 N-[2-(2,5-二甲氧基苯基)乙基]邻苯二甲酰亚胺
  参考文献：
  名称：

  氘标记苯乙胺衍生物的合成

  摘要：

  一系列五种氘标记的苯乙胺衍生物的合成，4-溴-2,5-[2H6]-二甲氧基苯乙胺（2C-B），4-氯-2,5-[2H6]-二甲氧基苯乙胺（2C-C）， 2,5-[2H6]-二甲氧基-4-碘苯乙胺 (2C-I)、2,5-[2H6]-二甲氧基-4-乙基噻吩乙胺 (2C-T-2) 和 2,5-[2H6]-二甲氧基-描述了来自 1,4-[2H6]-二甲氧基苯的 4-n-丙基噻吩乙胺 (2C-T-7)。同位素标记的化合物用作气相色谱-质谱 (GC-MS) 分析中的内标。版权所有 © 2006 John Wiley & Sons, Ltd.

  DOI：

  10.1002/jlcr.1139

文献信息

• Synthesis of Condensed Tetrahydroisoquinoline Class of Alkaloids by Employing TfOH-Mediated Imide Carbonyl Activation
  作者：Jayaraman Selvakumar、Ramana Sreenivasa Rao、Vijayan Srinivasapriyan、Srinivasan Marutheeswaran、Chinnasamy Ramaraj Ramanathan

  DOI：10.1002/ejoc.201403617

  日期：2015.4

  isoindoloisoquinolinones, pyrroloisoquinolinones, and benzo[a]quinolizinones were successfully assembled from the corresponding imides by using a TfOH-mediated (TfOH = trifluoromethanesulfonic acid) imide carbonyl activation and cyclization strategy. By employing this simple method, the isoquinoline alkaloids crispine A, trolline/oleracein E, and erythrinarbine were successfully synthesized in racemic form. The reaction

  通过使用 TfOH 介导的（TfOH = 三氟甲磺酸）酰亚胺羰基活化和环化策略，从相应的酰亚胺成功组装了基于异喹啉的多环内酰胺，例如异吲哚异喹啉酮、吡咯并异喹啉酮和苯并 [a] 喹啉酮。通过使用这种简单的方法，异喹啉生物碱松脆 A、三乙醇胺/油茶素 E 和红菊素以外消旋形式成功合成。不对称 N-苯乙基邻苯二甲酰亚胺与 TfOH 的反应显示出优异的区域选择性，这通过 DFT 计算得到了合理化。
• Synthesis of deuterium labeled phenethylamine derivatives
  作者：Ya-Zhu Xu、Chinpiao Chen

  DOI：10.1002/jlcr.1139

  日期：2006.11

  The synthesis of a series of five deuterium labeled phenethylamine derivatives, 4-bromo-2,5-[2H6]-dimethoxyphenethylamine (2C-B), 4-chloro-2,5-[2H6]-dimethoxyphenethylamine (2C-C), 2,5-[2H6]-dimethoxy-4-iodophenethylamine (2C-I), 2,5-[2H6]-dimethoxy-4-ethylthiophenethylamine (2C-T-2) and 2,5-[2H6]-dimethoxy-4-n-propylthiophenethylamine (2C-T-7) from 1,4-[2H6]-dimethoxybenzene is described. The isotopically

  一系列五种氘标记的苯乙胺衍生物的合成，4-溴-2,5-[2H6]-二甲氧基苯乙胺（2C-B），4-氯-2,5-[2H6]-二甲氧基苯乙胺（2C-C）， 2,5-[2H6]-二甲氧基-4-碘苯乙胺 (2C-I)、2,5-[2H6]-二甲氧基-4-乙基噻吩乙胺 (2C-T-2) 和 2,5-[2H6]-二甲氧基-描述了来自 1,4-[2H6]-二甲氧基苯的 4-n-丙基噻吩乙胺 (2C-T-7)。同位素标记的化合物用作气相色谱-质谱 (GC-MS) 分析中的内标。版权所有 © 2006 John Wiley & Sons, Ltd.
• Brønsted acid assisted activation of imide carbonyl group: regioselective synthesis of isoindoloisoquinolinone alkaloid (±)-nuevamine
  作者：Jayaraman Selvakumar、Chinnasamy Ramaraj Ramanathan

  DOI：10.1039/c1ob06349a

  日期：——

  Activation of imide carbonyl group with trifluoromethanesulfonic acid facilitates the intramolecular cyclization of phenethylphthalimides to give a fused isoindoloisoquinolinone skeleton. The first one pot regioselective synthesis of isoindoloisoquinolinone alkaloid (±)-nuevamine has been successfully executed using this methodology.

  用三氟甲磺酸活化酰亚胺羰基有助于苯乙基邻苯二甲酰亚胺的分子内环化，从而得到融合的异吲哚异喹啉酮骨架。利用这种方法，首次成功地进行了异吲哚异喹啉酮生物碱 (±)-nuevamine 的一锅区域选择性合成。
• 5-HT_2A/5-HT_2C Receptor Pharmacology and Intrinsic Clearance of <i>N</i>-Benzylphenethylamines Modified at the Primary Site of Metabolism
  作者：Sebastian Leth-Petersen、Ida N. Petersen、Anders A. Jensen、Christoffer Bundgaard、Mathias Bæk、Jan Kehler、Jesper L. Kristensen

  DOI：10.1021/acschemneuro.6b00265

  日期：2016.11.16

  The toxic hallucinogen 25B-NBOMe is very rapidly degraded by human liver microsomes and has low oral bioavailability. Herein we report on the synthesis, microsomal stability, and S-HT2A/5-HT2C receptor profile of novel analogues of 25B-NBOMe modified at the primary site of metabolism. Although microsomal stability could be increased while maintaining potent 5-HT2 receptor agonist properties, all analogues had an intrinsic clearance above 1.3 L/kg/h predictive of high first-pass metabolism.
• Synthesis and biological evaluation of isoindoloisoquinolinone, pyroloisoquinolinone and benzoquinazolinone derivatives as poly(ADP-ribose) polymerase-1 inhibitors
  作者：Arumugam Suyavaran、Chitteti Ramamurthy、Ramachandran Mareeswaran、Yagna Viswa Shanthi、Jayaraman Selvakumar、Selvaraj Mangalaraj、Muthuvel Suresh Kumar、Chinnasamy Ramaraj Ramanathan、Chinnasamy Thirunavukkarasu

  DOI：10.1016/j.bmc.2014.12.017

  日期：2015.2

  A series of novel fused isoquinolinones with isoindoloisoquinolinone, pyroloisoquinolinone, and benzoquinalizinone skeletons were synthesized from corresponding phenethylimides. The isoquinolinone derivatives were evaluated for their protective effect on chicken erythrocytes subjected to oxidative damage. The effect of isoquinolinone derivatives were analysed by estimation of cell viability, antioxidant enzyme activities, DNA damage (comet assay), PARP-1 inhibition assay and molecular docking of the compounds with PARP-1 active site. The compounds CRR-271, CRR-288 and CRR-224+225 showed significant protective effect at 100 mu M concentration. The PARP-1 inhibition assay revealed the IC50 values of CRR-271, CRR-288 and CRR-224+225 as <200 nM, further molecular docking studies shows higher binding energies with PARP-1 active site. Interesting findings in this study suggest that the novel isoquinolinone derivatives inhibit PARP-1 activity and protect cells against oxidative DNA damage, which could be implemented in the treatment of inflammatory diseases. (C) 2014 Elsevier Ltd. All rights reserved.